Rani Therapeutics Holdings (RANI) FCF Margin (2020 - 2026)
Rani Therapeutics Holdings (RANI) posted quarterly FCF Margin of 381.26% for Q1 2026, up 438618.0% year-over-year from N/an in Q1 2025, and down 2047.65% quarter-over-quarter from 19.58% in Q4 2025.
Rani Therapeutics Holdings (RANI) FCF Margin (2020 - 2026) Analysis & Trends
Rani Therapeutics Holdings' FCF Margin history runs 5 years deep, the most recent figure standing at 381.26% for Q1 2026.
- In Q1 2026, FCF Margin rose 438618.0% year-over-year to 381.26%; the TTM figure through Mar 2026 stood at 540.04% (up 233862.0% YoY), while the FY2025 annual figure was 1151.38%, up 232761.0% from the prior year.
- FCF Margin for Q1 2026 stood at 381.26%, down from 19.58% in the prior quarter.
- The five-year high for FCF Margin was 19.58% in Q4 2025, with the low at 4767.44% in Q1 2025.
- The 3-year median for FCF Margin is 613.1% (2024), against an average of 1493.52%.
- The sharpest annual moves came in 2025 and 2026: FCF Margin soared 86452 bps in 2025, then surged 438618 bps in 2026.
- Rani Therapeutics Holdings' FCF Margin stood at 844.94% in 2024, then jumped by 102 bps to 19.58% in 2025, then tumbled by 2048 bps to 381.26% in 2026.
- Business Quant data shows RANI's FCF Margin at 381.26% in Q1 2026, 19.58% in Q4 2025, and 4767.44% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | Rani Therapeutics Holdings | 160.33 Mn | 160.33 Mn | - | -530.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -530.15% |
| Mar 31, 2026 | -381.26% |
| Dec 31, 2025 | 19.58% |
| Mar 31, 2025 | -4,767.44% |
| Dec 31, 2024 | -844.94% |
| Jun 30, 2021 | -296.02% |
| Mar 31, 2021 | -543.12% |
| Dec 31, 2020 | -3,570.48% |
| Sep 30, 2020 | 1,122.22% |